Day: March 31, 2021

Q-Centrix Introduces the First Enterprise Clinical Data Management Platform

Written by Customer Service on March 31, 2021. Posted in Mergers And Acquisitions.

Chicago, March 31, 2021 (GLOBE NEWSWIRE) — Q-Centrix®, the leading source for clinical data management in health care, announced today it acquired Cleveland-based, software and services provider, CHAMPS Oncology. The move comes weeks after the market-leader purchased the Quantros® Regulatory Reporting Manager (RRM) software division. These events, coupled with the continued advancement of the Q-Apps® technology platform, a build out of the Q-Centrix data warehouse, and earlier acquisitions, represent breakthrough progress in the realization of its’ strategy—to help hospitals unlock the value of clinical data through the release of the industry’s first SOC2 + HITRUST certified enterprise-class clinical data management platform. “Over the past 24 months, we have diligently executed our strategy by expanding clinical expertise and technology...

PR 2020 Financial Results

Written by Customer Service on March 31, 2021. Posted in Public Companies.

CPI FIM SA2020 Financial ResultsFinancial highlights AttachmentPR_CPI_FIM_2020_Final

Blue Vision A/S – Årsrapport 2020

Written by Customer Service on March 31, 2021. Posted in Public Companies.

Dato: 31. marts 2021 Årets meddelelse nr.:10 Året i hovedtræk Bestyrelsen for Blue Vision A/S har dags dato behandlet og godkendt Selskabets årsrapport for 2020, som i hovedtræk kan sammenfattes, som følger: Årets resultat blev -32,9 mio.kr. mod -14,4 mio. kr. i 2019. Resultatet er særligt negativt påvirket af tab og hensættelser på 16,6 mio. kr., som følge af den fejlslagne investering i Heartcare ApS og dets datterselskaber. Heri indgår hensættelser for i alt 10 mio.kr. til dækning af selvskyldnerkautioner, som Blue Vision A/S har påtaget sig i medfør af Heartcare transaktionen. Der er endvidere foretaget en regnskabsteknisk regulering af Portinho tilgodehavendet, som påvirker resultat negativt med yderligere 13,8 mio. kr. Selskabets egenkapital er i 2020 faldet med 32,9 mio. kr., idet egenkapitalen pr. 31. december 2020 udgør 34,3...

NorthWest Copper Announces Closing of C$13.0 Million Bought Deal Private Placement

Written by Customer Service on March 31, 2021. Posted in Public Companies.

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES VANCOUVER, British Columbia, March 31, 2021 (GLOBE NEWSWIRE) — NorthWest Copper Corp. (“NorthWest Copper” or the “Company“) (TSXV:NWST) is pleased to announce that it has closed the previously announced bought deal private placement offering (the “Offering”) for aggregate gross proceeds of C$13,005,000 consisting of 3,750,000 common shares (the “Shares”), 5,000,000 flow-through common shares (the “FT Shares”), and 4,550,000 charity flow-through common shares (the “Charity FT Shares”). The FT Shares and the Charity FT Shares qualify as “flow-through shares” within the meaning of the Income Tax Act (Canada). “We are very...

Dorel Completes Sale of China Manufacturing Facility

Written by Customer Service on March 31, 2021. Posted in Public Companies.

MONTRÉAL, March 31, 2021 (GLOBE NEWSWIRE) — Dorel Industries Inc. (TSX: DII.B, DII.A) today announced that it has completed the previously-announced sale of its juvenile products manufacturing facility in Zhongshan, China to Guangdong Roadmate Group Co., Ltd. (“Roadmate”) and has received the gross sale proceeds of approximately US$51 million from Roadmate. As previously announced, Dorel will maintain its second manufacturing location in Huangshi, China as well as its product sourcing and quality control organizations in China that service all three of Dorel’s business segments. The sale transaction to Roadmate did not include Dorel Juvenile’s domestic sales operation based in Shanghai that was acquired along with the manufacturing facility in 2014. About DorelDorel Industries Inc. (TSX: DII.B, DII.A) is a global organization, operating...

Dorel finalise la vente d’une usine de fabrication en Chine

Written by Customer Service on March 31, 2021. Posted in Public Companies.

MONTRÉAL, 31 mars 2021 (GLOBE NEWSWIRE) — La société Les Industries Dorel Inc. (TSX : DII.B, DII.A) a annoncé aujourd’hui la finalisation de la vente précédemment annoncée de son usine de fabrication de produits de puériculture de Zhongshan, en Chine, à Guangdong Roadmate Group Co., Ltd. (« Roadmate »). En contrepartie de cette vente, Dorel a reçu un produit brut d’environ 51 millions de dollars US de la part de Roadmate. Comme elle en avait fait part antérieurement, Dorel conservera sa deuxième usine de fabrication située à Huangshi, en Chine, de même que ses équipes qui assurent l’approvisionnement en produits et le contrôle de la qualité en Chine et qui desservent les trois divisions de Dorel. La transaction de vente conclue avec Roadmate ne comprenait pas les activités de vente sur le marché intérieur de la division Dorel Produits...

HEALTHTECH SOLUTIONS, INC. ANNOUNCES CONTRACT TO ACQUIRE VARIAN BIOPHARMACEUTICALS, A PRECISION ONCOLOGY COMPANY

Written by Customer Service on March 31, 2021. Posted in Public Companies.

NEW YORK, March 31, 2021 (GLOBE NEWSWIRE) — via InvestorWire – Healthtech Solutions, Inc. (OTC: HLTT) (“HLTT” or the “Company”) today announces that it has entered into an agreement to acquire a wholly-owned subsidiary, Healthtech Oncology, Inc., which will own a 100% interest in Varian Biopharmaceuticals Inc. (“Varian Bio”), a precision oncology company developing novel therapeutics for the treatment of cancer. Varian Bio is developing a proprietary atypical protein kinase C iota (“aPKCi”) inhibitor for the treatment of various tumor types. Varian Bio’s lead drug candidate, VAR-101, is being developed in a topical formulation for the treatment of basal cell carcinoma. VAR-102, an oral formulation, is being developed for the treatment of a wide variety of solid tumors where studies have shown potent aPKCi inhibition would be impactful,...

Exploration Amseco Ltée annonce une assemblée annuelle et extraordinaire des actionnaires

Written by Customer Service on March 31, 2021. Posted in Public Companies.

Émission d’actions en conversion de dettes Régime d’option d’achat d’actions Regroupement d’actions Reprise de négociation des titresMONTRÉAL, 31 mars 2021 (GLOBE NEWSWIRE) — (TSXV: AEL.H) Exploration Amseco Ltée (« Amseco » ou « la Société ») annonce qu’une assemblée annuelle et extraordinaire des actionnaires se tiendra le 26 avril 2021. Les résolutions suivantes seront soumises au vote des actionnaires :L’émission de 268 719 actions ordinaires de la Société au prix de 0,06 $ par action aux administrateurs et officiers en conversion de dettes pour services rendus, approuvée par le TSX le 14 janvier 2019, mais conditionnelle au vote des actionnaires désintéressés; L’émission de 566 666 actions ordinaires de la Société au prix de 0,06 $ par action aux administrateurs et officiers en conversion de dettes pour services rendus,...

Net Element Reports Full Year 2020 Financial Results, Updates Shareholders on Pending Merger with Mullen Technologies

Written by Customer Service on March 31, 2021. Posted in Public Companies.

MIAMI, March 31, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Net Element, Inc. (NASDAQ:NETE) (“Net Element” or the “Company”), today reports its financial results for the calendar year ended December 31, 2020, and updates shareholders on the pending merger with privately-held Mullen Technologies, Inc. (“Mullen”), a Southern California-based electric vehicle (“EV”) company, in a stock-for-stock reverse merger in which, subject to consummation, Mullen’s stockholders will receive a majority of the outstanding stock in the post-merger Company. Mullen has completed its required financial audits and both companies are working to finalize the Form S-4 which is expected to be filed with the Securities and Exchange Commission. “We would like to reassure our shareholders that we continue working diligently on the pending merger with...

Informations relatives au nombre total de droits de vote et d’actions au 31 mars 2021

Written by Customer Service on March 31, 2021. Posted in Public Companies.

Informations relatives au nombre total de droits de vote et d’actionsprévues par l’article L. 233-8 II du code de commerce et l’article 223-16 du règlement général de l’Autorité des marchés financiers Date : 31/03/2021 Nombre d’actions : 119.628.977 Nombre total de droits de vote :Nombre de droits de vote théoriques : 119.628.977 Nombre de droits de vote exerçables : 119.628.977Le Président Directeur GénéralM. Richard Lonsdale-Hands Pièce jointe2021 03 31 Fonciere Paris Nord Informations relatives au nombre total de droits de vote et d’actions

Day: March 31, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals